Prognostic Model for Acute Myeloid Leukemia Using Ferroptosis-Related lncRNA
Author Information
Author(s): Liu Shuhan, Chen Yingli, Li Qianzhong, Fan Zhiyu, Li Menglan, Du Pengyu
Primary Institution: Inner Mongolia University
Hypothesis
The study investigates the role of ferroptosis-related lncRNA in the prognosis of acute myeloid leukemia (AML).
Conclusion
The prognostic model based on ferroptosis-related lncRNA can effectively predict survival outcomes in AML patients.
Supporting Evidence
- The model was validated using Kaplan-Meier analysis and Cox regression analysis.
- Patients in the low risk group had better survival than those in the high risk group.
- The AUC for 3-year and 5-year survival rates was predicted at 0.83 and 0.84 for the training set.
- High-risk patients may respond better to immunotherapy.
- Prognostic modeling may be useful for predicting the prognosis of AML patients.
Takeaway
Researchers created a model to help predict how well patients with a type of blood cancer called AML will do based on certain genes related to cell death.
Methodology
The study used univariate Cox analysis, LASSO analysis, and multivariate Cox analysis to construct and validate the prognostic model.
Limitations
The study may have limitations related to sample size and the generalizability of the findings.
Participant Demographics
The study included AML patients categorized into high and low risk groups based on their prognostic scores.
Statistical Information
P-Value
p<0.001
Confidence Interval
1.020–1.049
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website